Caxton Associates (New York)’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-9,082
Closed -$265K – 518
2020
Q1
$265K Buy
+9,082
New +$355K 0.05% 286
2019
Q4
– Sell
-10,426
Closed -$404K – 443
2019
Q3
$404K Buy
+10,426
New +$413K 0.08% 180
2018
Q4
– Sell
-15,910
Closed -$487K – 351
2018
Q3
$487K Buy
+15,910
New +$483K 0.03% 234
2018
Q1
– Sell
-28,456
Closed -$903K – 364
2017
Q4
$903K Buy
28,456
+5,056
+22% +$157K 0.04% 222
2017
Q3
$673K Buy
+23,400
New +$666K 0.02% 242

Other funds holding G

Caxton Associates (New York)'s G Position: Q2 2020 in Review

Caxton Associates (New York) sold out of Genpact (G) in Q2 2020, closing a stake of 9,082 shares — an estimated $265K sold.

Caxton Associates (New York) first reported a position in G in Q3 2017 and held it in 5 quarters. The position peaked at $903K in Q4 2017. 274 funds tracked by Wall St. Rank hold G as of Q2 2020.

  • Caxton Associates (New York) reported no remaining Genpact position as of Q2 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 9,082 Genpact shares in Q2 2020, an estimated $265K.
  • Caxton Associates (New York) first reported a position in Genpact in Q3 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s Genpact position peaked at $903K in Q4 2017.
  • 274 funds tracked by Wall St. Rank held Genpact as of Q2 2020.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.